- Home
- BBCP vs ORGO Comparison
BBCP vs ORGO Comparison
Compare BBCP & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- ORGO
- Stock Information
- Founded
- BBCP 1983
- ORGO 1985
- Country
- BBCP United States
- ORGO United States
- Employees
- BBCP N/A
- ORGO N/A
- Industry
- BBCP Engineering & Construction
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- BBCP Consumer Discretionary
- ORGO Health Care
- Exchange
- BBCP Nasdaq
- ORGO Nasdaq
- Market Cap
- BBCP 323.1M
- ORGO 384.4M
- IPO Year
- BBCP 2017
- ORGO N/A
- Fundamental
- Price
- BBCP $6.26
- ORGO $3.69
- Analyst Decision
- BBCP Buy
- ORGO Buy
- Analyst Count
- BBCP 2
- ORGO 2
- Target Price
- BBCP $7.00
- ORGO $5.50
- AVG Volume (30 Days)
- BBCP 120.2K
- ORGO 984.0K
- Earning Date
- BBCP 06-05-2025
- ORGO 08-07-2025
- Dividend Yield
- BBCP N/A
- ORGO N/A
- EPS Growth
- BBCP N/A
- ORGO N/A
- EPS
- BBCP 0.23
- ORGO N/A
- Revenue
- BBCP $401,503,000.00
- ORGO $458,760,000.00
- Revenue This Year
- BBCP N/A
- ORGO $2.62
- Revenue Next Year
- BBCP $4.28
- ORGO $12.46
- P/E Ratio
- BBCP $27.49
- ORGO N/A
- Revenue Growth
- BBCP N/A
- ORGO 5.35
- 52 Week Low
- BBCP $4.78
- ORGO $2.28
- 52 Week High
- BBCP $9.68
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- BBCP 49.61
- ORGO 58.16
- Support Level
- BBCP $6.10
- ORGO $3.13
- Resistance Level
- BBCP $6.41
- ORGO $3.69
- Average True Range (ATR)
- BBCP 0.25
- ORGO 0.22
- MACD
- BBCP 0.01
- ORGO 0.09
- Stochastic Oscillator
- BBCP 91.80
- ORGO 87.01
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.